MCID: ATM020
MIFTS: 39

Autoimmune Enteropathy malady

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Autoimmune Enteropathy

Aliases & Descriptions for Autoimmune Enteropathy:

Name: Autoimmune Enteropathy 50 69

Classifications:



Summaries for Autoimmune Enteropathy

MalaCards based summary : Autoimmune Enteropathy is related to rheumatoid arthritis and autoimmune enteropathy type 3. An important gene associated with Autoimmune Enteropathy is USH1C (USH1 Protein Network Component Harmonin), and among its related pathways/superpathways are Allograft rejection and Th17 cell differentiation. The drugs Methotrexate and Azathioprine have been mentioned in the context of this disorder. Affiliated tissues include skin, kidney and thyroid, and related phenotypes are digestive/alimentary and hematopoietic system

Wikipedia : 71 Autoimmune enteropathy (AIE) is a rare disorder of the immune system condition that affects infants,... more...

Related Diseases for Autoimmune Enteropathy

Diseases in the Autoimmune Enteropathy family:

Autoimmune Enteropathy Type 3 Autoimmune Enteropathy Type 2

Diseases related to Autoimmune Enteropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 60)
id Related Disease Score Top Affiliating Genes
1 rheumatoid arthritis 28.7 FOXP3 ICAM1 IL17A IL2RA ITGAL
2 autoimmune enteropathy type 3 11.9
3 autoimmune enteropathy type 2 11.9
4 immunodeficiency 41 with lymphoproliferation and autoimmunity 11.0
5 autoimmune disease, multisystem, infantile-onset 11.0
6 immunodeficiency 31c, autosomal dominant 10.9
7 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.9
8 pseudohypoaldosteronism, type iic 10.2 FOXP3 IL2RA
9 metal allergy 10.1 FOXP3 ICAM1
10 lateral body wall defect 10.1 IL2RA STAT3
11 smooth muscle tumor 10.1 IL17A IL2RA
12 central sleep apnea 10.1 ICAM1 IL17A
13 rosacea conjunctivitis 10.1 FOXP3 IL17A
14 cerebral sarcoidosis 10.1 IL2RA STAT3
15 erb-duchenne and dejerine-klumpke palsies 10.1 ICAM1 IL2RA
16 cortical dysplasia, complex, with other brain malformations 4 10.1 IL17A STAT3
17 fanconi anemia, complementation group f 10.1 LNX1 USH1C
18 choanal atresia, bilateral 10.1 IL17A IL2RA
19 phaeohyphomycosis 10.0 FOXP3 IL17A
20 squamous cell papilloma of skin 10.0 FOXP3 IL2RA
21 neonatal jaundice 10.0 FOXP3 ICAM1 IL17A
22 collagenous colitis 10.0 FOXP3 ICAM1 IL17A
23 esophageal candidiasis 10.0 ICAM1 IL17A IL2RA
24 macrodactyly of the foot 10.0 ICAM1 ITGAL
25 crohn's colitis 10.0 IL17A STAT3
26 non-gestational choriocarcinoma 10.0 IL17A STAT3
27 vulvar nodular hidradenoma 10.0 IL17A IL2RA STAT3
28 glycogen storage disease ix 10.0 FOXP3 IL17A STAT3
29 denys-drash syndrome 9.9 FOXP3 IL17A
30 advanced sleep phase syndrome, familial, 1 9.9 FOXP3 ICAM1 IL17A IL2RA
31 diabetes mellitus, insulin-dependent, 12 9.9 ICAM1 IL2RA ITGAL
32 coarctation of aorta 9.8 IL2RA ITGAL STAT3
33 colitis 9.8
34 thymoma 9.8
35 thrombosis 9.7
36 mucositis 9.7
37 hepatitis 9.7
38 vasculitis 9.7
39 immunodeficiency due to defect in mapbp-interacting protein 9.7 FOXP3 ICAM1 IL17A ITGAL
40 lymphoma 9.6
41 atrophic gastritis 9.6
42 enteropathica 9.6
43 enteropathy-associated t-cell lymphoma 9.6
44 diarrhea 9.6
45 down syndrome 9.6
46 celiac disease 9.6
47 hepatitis c 9.6
48 acrodermatitis enteropathica 9.6
49 acrodermatitis 9.6
50 cerebritis 9.6

Graphical network of the top 20 diseases related to Autoimmune Enteropathy:



Diseases related to Autoimmune Enteropathy

Symptoms & Phenotypes for Autoimmune Enteropathy

MGI Mouse Phenotypes related to Autoimmune Enteropathy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.73 FOXP3 ICAM1 IL17A IL2RA STAT3 USH1C
2 hematopoietic system MP:0005397 9.7 FOXP3 ICAM1 IL17A IL2RA ITGAL LNX1
3 immune system MP:0005387 9.5 ICAM1 IL17A IL2RA ITGAL LNX1 STAT3
4 vision/eye MP:0005391 9.02 FOXP3 ICAM1 IL2RA STAT3 USH1C

Drugs & Therapeutics for Autoimmune Enteropathy

Drugs for Autoimmune Enteropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 124)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 4 1959-05-2, 59-05-2 126941
2
Azathioprine Approved Phase 4,Phase 3 446-86-6 2265
3
Infliximab Approved Phase 4,Phase 3,Phase 1,Phase 2 170277-31-3
4
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
5 Hormone Antagonists Phase 4,Phase 2
6 Hormones Phase 4,Phase 2,Phase 3
7 Vaccines Phase 4,Phase 3,Phase 2
8 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
9 Immunoglobulins Phase 4,Phase 2,Phase 1
10 Antibodies Phase 4,Phase 2,Phase 1
11 glucocorticoids Phase 4,Phase 2
12 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
13 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
14 Dermatologic Agents Phase 4,Phase 3,Phase 1,Phase 2
15 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
16 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
17 Antimetabolites Phase 4,Phase 3,Phase 1,Phase 2
18 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 1,Phase 2
19 Antirheumatic Agents Phase 4,Phase 2,Phase 3,Phase 1
20 Antineoplastic Agents, Hormonal Phase 4,Phase 2
21
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
22
rituximab Approved Phase 2, Phase 3 174722-31-7 10201696
23
Naproxen Approved, Vet_approved Phase 3 22204-53-1 1302 156391
24
Esomeprazole Approved, Investigational Phase 3 161796-78-7, 119141-88-7 4594 9579578
25
Benzocaine Approved Phase 2, Phase 3 1994-09-7, 94-09-7 2337
26 tannic acid Approved, Nutraceutical Phase 2, Phase 3
27
Proton pump inhibitors Phase 3
28 Analgesics Phase 3,Phase 2
29 Adjuvants, Immunologic Phase 3
30 Cyclooxygenase Inhibitors Phase 3
31 Analgesics, Non-Narcotic Phase 3,Phase 2
32 Peripheral Nervous System Agents Phase 3,Phase 2
33 Antacids Phase 3
34 Anti-Inflammatory Agents, Non-Steroidal Phase 3
35 Anti-Ulcer Agents Phase 3
36
Cyclophosphamide Approved, Investigational Phase 2,Phase 1 50-18-0, 6055-19-2 2907
37
Adalimumab Approved Phase 1, Phase 2 331731-18-1 16219006
38
Lenograstim Approved Phase 2 135968-09-1
39
Xylometazoline Approved Phase 2 526-36-3 5709
40
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
41
Melphalan Approved Phase 2 148-82-3 4053 460612
42
Epinephrine Approved, Vet_approved Phase 2 51-43-4 5816
43
Acetaminophen Approved Phase 2 103-90-2 1983
44
Hydroxyurea Approved Phase 2 127-07-1 3657
45
Fludarabine Approved Phase 2 21679-14-1, 75607-67-9 30751
46
Vidarabine Approved Phase 2 24356-66-9 32326 21704
47
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
48
Diphenhydramine Approved Phase 2 58-73-1, 147-24-0 3100
49
Mesna Approved Phase 2 3375-50-6 598
50
alemtuzumab Approved, Investigational Phase 2 216503-57-0

Interventional clinical trials:

(show top 50) (show all 113)
id Name Status NCT ID Phase
1 Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease Completed NCT01981889 Phase 4
2 Pneumococcal Vaccination of Crohn Patients Completed NCT01947010 Phase 4
3 Centocor Microarray Study of Patients Completed NCT00462072 Phase 4
4 Remicade Infusion Management Program Completed NCT00723905 Phase 4
5 A Long-term Safety Study of Infliximab (Remicade) Completed NCT00261976 Phase 4
6 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. Completed NCT00440817 Phase 4
7 The NOR-SWITCH Study Active, not recruiting NCT02148640 Phase 4
8 Immunogenicity of HPV Vaccine in Immunosuppressed Children Completed NCT02263703 Phase 3
9 Rituximab in Active Ulcerative Colitis Completed NCT00261118 Phase 2, Phase 3
10 Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC Completed NCT00094458 Phase 3
11 Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. Completed NCT00367211 Phase 3
12 Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer Completed NCT00595517 Phase 3
13 Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID Completed NCT00542789 Phase 3
14 Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease Terminated NCT00511329 Phase 2, Phase 3
15 Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders Unknown status NCT01540292 Phase 1, Phase 2
16 A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis Unknown status NCT02463916 Phase 2
17 Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy Completed NCT00258180 Phase 2
18 An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease Completed NCT01090817 Phase 2
19 Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity Completed NCT00671138 Phase 2
20 Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease Completed NCT00287170 Phase 1, Phase 2
21 Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease Completed NCT00138840 Phase 2
22 Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease Completed NCT00234741 Phase 2
23 FolateScan in Autoimmune Disease Completed NCT00588393 Phase 2
24 Cytokine Profile in Children With Celiac Disease Completed NCT02244047 Phase 1, Phase 2
25 Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma Completed NCT00773097 Phase 2
26 Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Completed NCT00266565 Phase 1, Phase 2
27 Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia Recruiting NCT03033199 Phase 2
28 Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Recruiting NCT02647866 Phase 2
29 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Recruiting NCT01988506 Phase 2
30 High-dose Cyclophosphamide for Severe Refractory Crohn Disease Recruiting NCT01836289 Phase 1, Phase 2
31 Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) Recruiting NCT02000362 Phase 1, Phase 2
32 Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT Recruiting NCT01962415 Phase 2
33 Treating Anorectal Dysfunction in MS Recruiting NCT02609607 Phase 2
34 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Recruiting NCT02538341 Phase 2
35 Sirolimus for Autoimmune Disease of Blood Cells Active, not recruiting NCT00392951 Phase 1, Phase 2
36 Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE) Active, not recruiting NCT02538757 Phase 2
37 Study of Enzyme Supplements to Treat Celiac Disease Active, not recruiting NCT00962182 Phase 1, Phase 2
38 Vedolizumab Induction May Prevent Celiac Enteritis Not yet recruiting NCT02929316 Phase 2
39 Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease Terminated NCT00325078 Phase 1, Phase 2
40 Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome Terminated NCT01413243 Phase 2
41 An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease Terminated NCT01009281 Phase 2
42 Autologous Stem Cell Transplant for Refractory Crohn's Disease Withdrawn NCT02676622 Phase 2
43 Oral AGY for Celiac Disease Completed NCT01765647 Phase 1
44 A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta Completed NCT02019602 Phase 1
45 A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Completed NCT02154425 Phase 1
46 Antibody Treatment for Advanced Celiac Disease Recruiting NCT01893775 Phase 1
47 Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease Unknown status NCT00291681
48 Volatile Organic Compounds (VOCs) and Liver Diseases Unknown status NCT01279356
49 Telomeres Parameters in Celiac Disease Unknown status NCT02126033
50 Celiac Disease Prevention Unknown status NCT00617838

Search NIH Clinical Center for Autoimmune Enteropathy

Genetic Tests for Autoimmune Enteropathy

Anatomical Context for Autoimmune Enteropathy

MalaCards organs/tissues related to Autoimmune Enteropathy:

39
Skin, Kidney, Thyroid, T Cells, Bone

Publications for Autoimmune Enteropathy

Articles related to Autoimmune Enteropathy:

(show top 50) (show all 75)
id Title Authors Year
1
Adult autoimmune enteropathy presenting initially with acquired Acrodermatitis Enteropathica: a case report. ( 28521835 )
2017
2
Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy. ( 27415620 )
2016
3
Autoimmune enteropathy: not all flat mucosa mean coeliac disease. ( 27099674 )
2016
4
Severe Malabsorption Refractory to Pancreatic Enzyme Supplementation Unmasking Autoimmune Enteropathy in a Chronic Pancreatitis Patient. ( 27518366 )
2016
5
A Difficult and Rare Diagnosis of Autoimmune Enteropathy in a Patient Affected by Down Syndrome. ( 27072857 )
2016
6
Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy. ( 26101883 )
2015
7
Wireless capsule endoscopy as a tool in diagnosing autoimmune enteropathy. ( 26150615 )
2015
8
Recalcitrant Hypocalcaemia in Autoimmune Enteropathy. ( 25404718 )
2014
9
Gastrointestinal biopsy findings of autoimmune enteropathy: a review of 25 cases. ( 25188868 )
2014
10
Diffuse Autoimmune Enteropathy and Colopathy in an Adult Patient Successfully Treated With Adalimumab and a Review of the Literature. ( 25379737 )
2014
11
Autoimmune enteropathy in a 13-year-old celiac girl successfully treated with infliximab. ( 24504079 )
2014
12
Glutamine-supplemented parenteral nutrition and probiotics in four adult autoimmune enteropathy patients. ( 24827631 )
2014
13
Abatacept: a new treatment option for refractory adult autoimmune enteropathy. ( 24045285 )
2014
14
Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency disorders. ( 24051695 )
2013
15
A Case of Isolated Autoimmune Enteropathy Associated with Autoantibodies to a Novel 28 kilodalton Duodenal Antigen. ( 23969534 )
2013
16
Autoimmune enteropathy: a review and update of clinical management. ( 22810979 )
2012
17
Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathy. ( 22958995 )
2012
18
Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy. ( 22226659 )
2012
19
Autoimmune enteropathy with a CD8+ CD7- T-cell small bowel intraepithelial lymphocytosis: case report and literature review. ( 22126605 )
2011
20
Autoimmune enteropathy associated with cessation of interferon-alpha therapy in chronic hepatitis C. ( 19639409 )
2010
21
Cerebral venous thrombosis in autoimmune enteropathy. ( 20186248 )
2010
22
Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. ( 20537998 )
2010
23
Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. ( 19940509 )
2010
24
From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome. ( 19912978 )
2009
25
Autoimmune enteropathy in children and adults. ( 19255930 )
2009
26
Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy? ( 19956142 )
2009
27
Adult autoimmune enteropathy. ( 18300339 )
2008
28
Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. ( 18420833 )
2008
29
Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome. ( 19122524 )
2008
30
Autoimmune enteropathy in Swedish children, 1985-2002: a call for strict diagnostic criteria. ( 18609171 )
2008
31
Severe FOXP3+ and naA^ve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. ( 17484867 )
2007
32
Adult autoimmune enteropathy: Mayo Clinic Rochester experience. ( 17683994 )
2007
33
Association between thymoma and autoimmune enteropathy in adults. ( 16996380 )
2006
34
Autoimmune enteropathy and rheumatoid arthritis: a new association in the field of autoimmunity. ( 16920048 )
2006
35
Enteropathy with loss of enteroendocrine and paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy. ( 16613334 )
2006
36
Adult-onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab. ( 15906770 )
2005
37
Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus. ( 15785040 )
2005
38
Autoimmune enteropathy: molecular concepts. ( 15703687 )
2004
39
Autoimmune enteropathy and colitis in an adult patient. ( 12924654 )
2003
40
Autoimmune enteropathy. ( 12952510 )
2003
41
Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. ( 12717089 )
2003
42
Adult autoimmune enteropathy treated successfully with tacrolimus. ( 14581765 )
2003
43
Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil. ( 12658040 )
2003
44
Autoimmune enteropathy in a child: response to infliximab therapy. ( 11964960 )
2002
45
Possible autoimmune enteropathy found in autistic children. ( 12020535 )
2002
46
Autoimmune enteropathy in an adult with autoimmune multisystemic involvement. ( 12374224 )
2002
47
Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. ( 11982595 )
2002
48
Simultaneous occurrence of autoimmune enteropathy and recurrent deep venous thrombosis. ( 10749421 )
2000
49
Autoimmune enteropathy with goblet-cell antibodies. ( 10472291 )
1999
50
Autoimmune enteropathy. ( 9841709 )
1999

Variations for Autoimmune Enteropathy

Expression for Autoimmune Enteropathy

Search GEO for disease gene expression data for Autoimmune Enteropathy.

Pathways for Autoimmune Enteropathy

Pathways related to Autoimmune Enteropathy according to GeneCards Suite gene sharing:

(show all 19)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.29 FOXP3 ICAM1 IL17A IL2RA ITGAL
2
Show member pathways
12.21 FOXP3 IL17A IL2RA STAT3
3 12.09 ICAM1 IL2RA ITGAL
4 12.05 FOXP3 IL17A IL2RA STAT3
5 11.94 ICAM1 ITGAL STAT3
6 11.64 ICAM1 IL17A STAT3
7 11.45 ICAM1 IL17A ITGAL
8 11.33 ICAM1 ITGAL
9 11.27 ICAM1 STAT3
10 11.26 ICAM1 ITGAL
11 11.23 FOXP3 IL2RA
12
Show member pathways
11.23 FOXP3 ICAM1 IL17A STAT3
13
Show member pathways
11.19 IL2RA STAT3
14 11.18 ICAM1 ITGAL
15 11.17 ICAM1 STAT3
16
Show member pathways
11.1 FOXP3 IL2RA
17
Show member pathways
10.94 IL2RA STAT3
18 10.88 IL2RA STAT3
19 10.77 FOXP3 ICAM1 IL2RA ITGAL

GO Terms for Autoimmune Enteropathy

Cellular components related to Autoimmune Enteropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.8 ICAM1 IL17A IL2RA

Biological processes related to Autoimmune Enteropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.46 IL17A IL2RA ITGAL STAT3
2 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157 9.43 ICAM1 ITGAL
3 negative regulation of T cell proliferation GO:0042130 9.4 FOXP3 IL2RA
4 T cell homeostasis GO:0043029 9.37 FOXP3 IL2RA
5 leukocyte cell-cell adhesion GO:0007159 9.32 ICAM1 ITGAL
6 negative regulation of immune response GO:0050777 9.26 FOXP3 IL2RA
7 negative regulation of lymphocyte proliferation GO:0050672 8.96 FOXP3 IL2RA
8 T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell GO:0002291 8.62 ICAM1 ITGAL

Sources for Autoimmune Enteropathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....